Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Teva CEO Schultz Walks Smack Into A Rough Financial Situation

Nov 02 2017

• By Jessica Merrill

group of businessman in black suit and holding red arrow down graph

Related Content

Meet The New Teva: 8% Global Generics Share, 300 ANDAs, 1,500 Launches

Sep 15 2016

Surprise! Mylan's Copaxone Generic Sets Teva Up For A Struggle

Oct 04 2017

Generic Manufacturers Try To Up Their Game As US Pressure Persists

Jun 16 2017

Teva Offloads Women's Health Business To Two Firms For $1.38Bn

Sep 18 2017

Teva Lands A CEO: Can Schultz Replicate Lundbeck Success?

Sep 11 2017

Related Companies

Teva Pharmaceutical Industries Ltd.

H. Lundbeck A/S

Viatris Inc.

Novartis AG

Allergan plc

Additional Topics

Generic Drugs Leadership Sales & Earnings Business Strategies Commercial Companies BioPharmaceutical

More from Leadership

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window